ARCHIVES

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting

August 29, 2003

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

ACS Adopts ‘Measures of Success’ To Mark Progress T0 Yr. 2000

April 17, 1992

NCI, NSABP Launch Taxifin Trial For Prevention Of Breast Cancer

May 8, 1992

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

Steven Curley Named Chief of Surgical Oncology At Baylor’s Dan L. Duncan Cancer Center

October 4, 2013